ELFN2 is also involved in glioblastoma cell autophagy [71], pancreatic cancer radiotherapy resistance [72], gastric cancer invasion [67], and endometrial cancer progression [73]. This evidence concerns the gene ELFN2 and familial pancreatic carcinoma.